Birmingham Neil Patrick, Parvataneni Sitaram, Hassan Hanem M Ahmed, Harkema Jack, Samineni Sridhar, Navuluri Lalitha, Kelly Caleb James, Gangur Venu
Food Allergy and Immunology Laboratory, Department of Food Science and Human Nutrition, Nutritional Immunology Program, Michigan State University, East Lansing, Mich. 48823, USA.
Int Arch Allergy Immunol. 2007;144(3):203-10. doi: 10.1159/000103993. Epub 2007 Jun 15.
Tree nut allergy, a major group of food allergy, is often linked to fatal or near-fatal systemic anaphylaxis. Currently, an adjuvant-free mouse model to study tree nut hypersensitivity is unavailable. Here we tested the hypothesis that transdermal exposure to hazelnut, a model tree nut, without the use of an adjuvant is sufficient to sensitize mice for immediate hypersensitivity reaction to oral hazelnut challenge.
BALB/c mice were repeatedly exposed to hazelnut protein via the transdermal route and systemic allergic and anaphylactic responses were studied.
Transdermal exposure to hazelnut protein elicited robust systemic IgE response in a dose-dependent manner with immunological memory. Oral challenge of transdermally sensitized mice with hazelnut protein resulted in immediate (30 min after the challenge) clinical signs of systemic anaphylaxis as measured by significant clinical scores and drop in rectal temperature. Clinical hypersensitivity reaction was associated with severe pathological changes in the small intestine. Hazelnut-allergic but not control mice exhibited in vivo activation of GATA-3 and hazelnut-driven recall IL-4, IL-5 and IL-13 response by splenocytes, thus elucidating the underlying mechanism of hazelnut allergy development in this model.
These data suggest that (1) transdermal exposure to hazelnut protein is sufficient to activate the key immune pathways necessary for sensitizing mice for clinical immediate hypersensitivity reactions and (2) this mouse model may be useful for further basic and applied studies on tree nut allergy, especially because it does not depend on an adjuvant for eliciting immediate hypersensitivity reactions to nut protein.
坚果过敏是食物过敏的主要类型,常与致命或近乎致命的全身性过敏反应相关。目前,尚无用于研究坚果超敏反应的无佐剂小鼠模型。在此,我们测试了以下假设:经皮暴露于作为典型坚果的榛子,不使用佐剂就足以使小鼠对口服榛子激发产生速发型超敏反应致敏。
通过经皮途径使BALB/c小鼠反复暴露于榛子蛋白,并研究其全身过敏和过敏反应。
经皮暴露于榛子蛋白以剂量依赖方式引发强烈的全身IgE反应,并具有免疫记忆。用榛子蛋白对经皮致敏的小鼠进行口服激发,会导致立即(激发后30分钟)出现全身性过敏反应的临床症状,可通过显著的临床评分和直肠温度下降来衡量。临床超敏反应与小肠的严重病理变化相关。榛子过敏的小鼠而非对照小鼠在体内表现出GATA-3的激活以及脾细胞对榛子驱动的IL-4、IL-5和IL-13回忆反应,从而阐明了该模型中榛子过敏发展的潜在机制。
这些数据表明:(1)经皮暴露于榛子蛋白足以激活使小鼠对临床速发型超敏反应致敏所需的关键免疫途径;(2)该小鼠模型可能有助于进一步开展关于坚果过敏的基础和应用研究,特别是因为它不依赖佐剂来引发对坚果蛋白的速发型超敏反应。